FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT:
Catching Up with Califf:
Harnessing the Potential of Artificial Intelligence
At the FDA, we’ve been working for years to anticipate and prepare for the challenges of Artificial Intelligence, and also to harness its potential.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Photo of female pharmacist talking to female customer at counter of pharmacy.](/files/styles/medium_3/public/biosimilar_action_plan_1600x900.png?itok=MKRrH2eW)
A Milestone in Facilitating the Development of Safe and Effective Biosimilars
The 50th biosimilar approval milestone also reflects our strategic approach to biosimilars, as outlined in the FDA’s Biosimilars Action Plan.
![Photo collage - Background image of European Union flag. Top photo - exterior of European Medicines Agency (EMA) headquarters in Amsterdam. Bottom photo - interior of EMA headquarters.](/files/styles/medium_3/public/rmc_europe_trip-pt03_1600x900_0.png?itok=1HTs79dF)
Reflections on Travel to Europe – Part Three
I recently had the privilege of official travel to the European Union with our global affairs team.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|